Mettler Toledo management check
MTD · Health Care · Life Sciences Tools & Services · CEO Patrick Kaltenbach
Filings as of
Closest peers in Life Sciences Tools & Services
- 101WATWaters Corporation76
- 108MTDMettler Toledo76
- 151DHRDanaher Corporation72
- 168IQVIQVIA71
- 307TMOThermo Fisher Scientific61
- 375CRLCharles River Laboratories56
- 386AAgilent Technologies55
- 443ILMNIllumina, Inc.47
- 453TECHBio-Techne45
The seven checks
- GoodBeat its chosen peers
Have owners done well?
What $100 became since fiscal 2021
7068thDetail
$100 invested at the start of fiscal 2021 grew to $122, against $106 for the peer group the company picked itself.
- GoodPay rose and fell with returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
9273rdDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.84 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good0.8% of net income
What does the CEO cost owners?
$6.7m pay · $869.2m net income, FY2025
5960thDetail
$6.7m of reported pay in fiscal 2025, against $869.2m of net income.
- WatchInsiders are selling
Do they own the stock?
5,510 shares
6 mo: ▲ $0 bought · ▼ $6.8m sold
——Detail
4 insiders sold $6.8m in the last six months and none bought.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −3.0% a year; flagged above +2%
Stock pay 0.6% of revenue
8879thDetail
Diluted shares changed -3.0% a year over the last three fiscal years. Stock-based pay was 0.6% of revenue in the latest year.
- Watch2 CEOs in the pay table
Is leadership stable?
8 filings under 8-K 5.02 in 3 years
CEOs: Olivier Filliol, Patrick Kaltenbach
4521stDetail
CEOs in the pay table: Olivier Filliol, Patrick Kaltenbach. 8 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed March 18, 2026.
Other key measuresNon-GAAP earnings per shareNet cash flowGroup sales at budgeted currency ratesTotal shareholder return relative to the S&P 500 Healthcare Index and the S&P 500 Industrials Index
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Patrick Kaltenbach | $6.7m | $8.8m | $1.9m | $122 | $106 | $869.2m |
| 2024 | Patrick Kaltenbach | $6.9m | $6.5m | $1.6m | $107 | $102 | $863.1m |
| 2023 | Patrick Kaltenbach | $8.5m | $4.7m | $1.4m | $106 | $103 | $788.8m |
| 2022 | Patrick Kaltenbach | $6.5m | $4.6m | $1.5m | $127 | $109 | $872.5m |
| 2021 | Olivier Filliol, Patrick Kaltenbach | $12.0m | $17.2m | $2.0m | $149 | $139 | $769.0m |
Insiders and the CEO's stakeSelling
- President and CEO
- Patrick Kaltenbach
- Shares held
- 5,510
- Latest Form 4
- Nov 12, 2026
4 insiders sold $6.8m in the last six months and none bought.
Open-market trades by officers and directors since May 21, 2026.
- SoldShawn VadalaChief Financial Officer$3.2mAug 3, 2026
- SoldPatrick KaltenbachPresident and CEO$1.3mAug 27, 2026
- SoldThomas P SaliceDirector$1.2mAug 5, 2026
- SoldGerry KellerHead of Process Analytics$1.1mNov 9, 2026
Leadership and governance on file
All 14 filings
- Aug 3, 2026Leadership change8-K 5.02
- May 13, 2026Leadership change8-K 5.02
- Jan 20, 2026Leadership change8-K 5.02
- Oct 23, 2025Leadership change8-K 5.02
- Aug 4, 2025Leadership change8-K 5.02
- May 12, 2025Leadership change8-K 5.02
- Jun 26, 2024Leadership change8-K 5.02
- Dec 14, 2023Leadership change8-K 5.02
- Nov 13, 2023Leadership change8-K 5.02
- Aug 1, 2023Leadership change8-K 5.02
- Nov 23, 2022Leadership change8-K 5.02
- Nov 8, 2022Leadership change8-K 5.02
- Aug 1, 2022Leadership change8-K 5.02
- Feb 24, 2022Leadership change8-K 5.02
Latest shareholder vote results: May 11, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $4.6bn returned to owners in buybacks and dividends, 112% of net income, and $99.7m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.7bn | $3.9bn | $3.8bn | $3.9bn | $4.0bn |
| Net income | $769.0m | $872.5m | $788.8m | $863.1m | $869.2m |
| Stock-based pay | $19.6m | $19.7m | $17.9m | $20.0m | $22.5m |
| Buybacks | $1000.0m | $1.1bn | $900.0m | $850.0m | $800.0m |
| Dividends | — | — | — | — | — |
| Diluted shares | 23m | 23m | 22m | 21m | 21m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.